Michael J. Gelfand, MD
Title
Chief, Section of Nuclear Medicine
Appointment
Professor of Radiology and Pediatrics
Email
michael.gelfand@cchmc.org
Phone
513-636-7650
Fax
513-636-8145
Bio
Michael J. Gelfand, MD, is chief of the Section of Nuclear Medicine at Cincinnati Children's Hospital Medical Center.
He received his BA from the University of Michigan and his MD from Stanford University. After two years at the National Institutes of Health, he completed residencies in Pediatrics at Cincinnati Children's and Nuclear Medicine at the University of Cincinnati Medical Center.
Dr. Gelfand's research interests include I-123-MIBG imaging of neuroblastoma, studies of the clinical utility of genitourinary imaging in children, application of positron emission tomography (PET) and PET / CT in pediatric neoplasia and related diseases, and application of new PET radiopharmaceuticals for imaging in children.
Dr. Gelfand has served as President of the Society of Nuclear Medicine, and served on the Board of Directors of that organization for 10 years.
Dr. Gelfand co-edited the textbooks Effective Use of Computers in Nuclear Medicine and Pediatric Nuclear Imaging. His publications include 79 journal articles and 31 book chapters. He has been an invited lecturer or visiting professor in France, Germany, the Netherlands, Italy, Argentina, Brazil, Japan and Australia.
Credentials
BA: University of Michigan, Ann Arbor, MI, 1966.
MD: Stanford University, Stanford, CA, 1971.
Residency: Pediatrics, Cincinnati Children's, Cincinnati, OH, 1973-1975, 1977; Nuclear Medicine, University of Cincinnati, Cincinnati, OH, 1975 to 1977.
Certification: Pediatrics, 1978; Nuclear Medicine, 1978.
Awards and Honors
Research
- Imaging of neuroblastoma
- PET/CT imaging of pediatric tumors and related diseases
- New PET radiopharmaceuticals in children
- Genitourinary imaging
- Epidemological studies of urinary tract pathophysiology demonstrable by imaging
Publications, Most Recent
Gilbert, D.L., Christian, B.I., Gelfand, M.J., Shi, B., Mantil, J., Sallee, F.R. Altered mesolimbocortical and thalamic dopamine in Tourette Syndrome. Neurology, 2006; 67:1695- 1697.
Gelfand, M.J., O'Hara, S.M., Curtwright, L.A., MacLean, J.R. Pre-Medication to Block [18F]FDG Uptake in the Brown Adipose Tissue of Pediatric and Adolescent Patients. Pediatric Radiology, 2005; 35:984-990.
Presentations, Most Recent:
Gelfand, M.J. Pediatrics Review, Nuclear Medicine Board Review. Presented at the 54th Annual Meeting, Society of Nuclear Medicine: Washington, DC, June 2-6, 2007.
Gelfand, M.J. Imaging and Treatment of Pediatric Hyperthyroidism. Presented at the 54th Annual Meeting, Society of Nuclear Medicine: Washington, DC, June 2-6, 2007.
Gelfand, M.J. Pediatric PET: Optimizing Scan Quality and Interpretation. Presented at the 54th Annual Meeting, Society of Nuclear Medicine: Washington, DC, June 2-6, 2007.
Gelfand, M.J., Bleesing, J.J.H., Yazigi, N.A., Young, L.R., Sharp, S.E., Cooper, M.L. FDG PET imaging in lymphoproliferative and selected lymphocytic diseases. Presented at 50th Annual Meeting of the Society of Pediatric Radiology: Miami, Florida, April 18-21, 2007.
Professional Organization Memberships
Related Areas
This person works in these other areas at Cincinnati Children's Hospital Medical
Center:
